Motley Fool Asset Management LLC Raises Position in UiPath Inc. (NYSE:PATH)

Motley Fool Asset Management LLC boosted its stake in UiPath Inc. (NYSE:PATH) by 668.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 70,496 shares of the healthcare company’s stock after buying an additional 61,322 shares during the quarter. Motley Fool Asset Management LLC’s holdings in UiPath were worth $1,598,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Intech Investment Management LLC raised its holdings in UiPath by 3.1% in the 4th quarter. Intech Investment Management LLC now owns 14,324 shares of the healthcare company’s stock valued at $356,000 after acquiring an additional 426 shares during the last quarter. 180 Wealth Advisors LLC raised its holdings in UiPath by 0.3% in the 4th quarter. 180 Wealth Advisors LLC now owns 188,950 shares of the healthcare company’s stock valued at $4,497,000 after acquiring an additional 492 shares during the last quarter. Global Financial Private Client LLC raised its holdings in UiPath by 9.3% in the 1st quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock valued at $144,000 after acquiring an additional 551 shares during the last quarter. Bleakley Financial Group LLC raised its holdings in UiPath by 4.9% in the 4th quarter. Bleakley Financial Group LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after acquiring an additional 598 shares during the last quarter. Finally, Simplicity Solutions LLC raised its holdings in UiPath by 4.9% in the 4th quarter. Simplicity Solutions LLC now owns 12,691 shares of the healthcare company’s stock valued at $315,000 after acquiring an additional 598 shares during the last quarter. 62.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on PATH shares. Mizuho cut their price target on shares of UiPath from $25.00 to $14.00 and set a “neutral” rating for the company in a report on Thursday, May 30th. Truist Financial restated a “hold” rating and set a $14.00 price target (down previously from $32.00) on shares of UiPath in a report on Thursday, May 30th. DA Davidson cut their price target on shares of UiPath from $24.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, May 30th. Evercore ISI cut their price target on shares of UiPath from $27.00 to $13.00 and set an “in-line” rating for the company in a report on Thursday, May 30th. Finally, JPMorgan Chase & Co. cut their price target on shares of UiPath from $28.00 to $19.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Sixteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $18.06.

Insider Activity

In other news, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $19.79, for a total value of $791,600.00. Following the completion of the sale, the chief financial officer now directly owns 946,848 shares of the company’s stock, valued at $18,738,121.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 22.37% of the company’s stock.

UiPath Trading Up 0.9 %

Shares of PATH stock traded up $0.11 on Wednesday, reaching $12.17. 8,103,770 shares of the stock were exchanged, compared to its average volume of 9,821,418. The business’s 50 day moving average price is $12.84 and its 200 day moving average price is $18.87. The company has a market capitalization of $6.97 billion, a price-to-earnings ratio of -76.06 and a beta of 0.86. UiPath Inc. has a twelve month low of $11.07 and a twelve month high of $27.87.

UiPath (NYSE:PATH) last released its quarterly earnings data on Wednesday, May 29th. The healthcare company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03). UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. The company had revenue of $335.11 million during the quarter, compared to the consensus estimate of $332.84 million. Equities research analysts forecast that UiPath Inc. will post -0.22 earnings per share for the current year.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.